Back to Results
First PageMeta Content
Bristol-Myers Squibb / Amides / Dipeptidyl peptidase-4 inhibitors / Nitriles / Metformin / Dapagliflozin / Anti-diabetic medication / Sulfonylurea / Saxagliptin / Chemistry / Organic chemistry / Anti-diabetic drugs


Document Date: 2015-04-22 23:39:46

Open Document

File Size: 61,67 KB

Share Result on Facebook

City

Trial / Trials / /

Company

AstraZeneca Pty Ltd / Randomized / PBAC / Placebo / /

Country

Australia / /

Currency

USD / /

Event

Reorganization / FDA Phase / Product Issues / Music Album Release / /

IndustryTerm

treatment algorithm / /

MedicalCondition

genital mycotic infections / genital infections / diabetes / diabetes mellitus / Obesity / urinary tract infections / II diabetes / /

MedicalTreatment

alternative therapy / alternative therapies / oral therapy / /

MusicAlbum

Source / /

MusicGroup

Phase III / Placebo / /

Organization

Federal Government / /

Position

nurse / /

Product

500mg / XR tablets / 5mg / IR tablets / glucagon / Glucophage / XR tablet / 10mg / IR tablet / Metformin hydrochloride / CT-014 / CT-065 / Dapagliflozin / Glycaemic Control / /

Technology

treatment algorithm / submission Trial ID Protocol / PBS-subsidised treatment algorithm / /

SocialTag